Reduction amniocentesis is used in cases of severe polyhydramnios to decrease maternal discomfort and the risk of preterm labor. In a MED-LINE search (1966 to present, English language, keywords: amniocentesis, chorioamnionitis), no report of Candida chorioamnionitis after serial reduction amniocentesis exists.
Intraamniotic infection is recognized as an important etiologic factor for preterm delivery. 1 Organisms involved are usually common inhabitants of the lower genital tract. Although Candida species are frequently recovered from the vagina during pregnancy and are associated with preterm labor, antenatal fetal infections with this group of organisms are rare. 1 We report a case of chorioamnionitis and congenital candidiasis after serial amniocenteses for symptomatic polyhydramnios.
Case Report
A 29-year-old healthy primigravida was referred at 16 weeks' gestation for an increased risk of Down syndrome suggested by maternal serum testing. The pregnancy was otherwise without complication. Specifically, there was no history of intrauterine contraceptive device use, human immunodeficiency virus, or cervical cerclage. An ultrasonographic anatomic survey of the fetus demonstrated no structural abnormalities. Amniocentesis revealed a normal 46, XX karyotype.
Six weeks later, the patient presented for evaluation of uterine size greater than gestational age. Ultrasonographic measurement of the amniotic fluid index was 25 cm (Ͼ95% for gestational age). 2 Causes for polyhydramnios, including diabetes, Rh isoimmunization, and viral infection were not identified.
At 25 weeks' gestation, the patient experienced shortness of breath, uterine contractions, and severe discomfort secondary to uterine distention. A therapeutic amniocentesis was performed. Recurrent symptoms required additional reduction amniocenteses at 27 and 29 weeks' gestation. At each, 2000 to 3000 ml of amniotic fluid was removed, with the goal of a maximum vertical pocket of Ͻ8 cm. The amniotic fluid index ranged between 40 and 55 cm before the procedure to between 22 and 26 cm after completion of the amnioreduction. Because it was felt the patient was at high risk for preterm delivery, a single course of betamethasone (12 mg intramuscularly, repeated at 24 hours) was administered at 25 weeks' gestation.
At 30 and 5/7 weeks' gestation, she presented complaining of shortness of breath and discomfort. Vital signs were normal. The patient's abdomen was markedly distended. The amniotic fluid index was elevated at 47 cm. The cervical examination was changed from a stable fingertip of dilation without effacement first detected at 25 weeks' gestation to 3 cm of dilation and complete effacement with engagement of the fetal head. Uterine contractions were every 3 minutes.
Magnesium sulfate tocolysis was started. A fourth reduction amniocentesis was performed to decrease amniotic fluid volume to aid in terminating preterm labor. To rule out the possibility of an infectious etiology, amniotic fluid was sent for Gram stain and culture.
Hours later, the Gram stain returned positive for yeast with no bacteria or white blood cells, and the patient experienced spontaneous rupture of membranes. Tocolysis was discontinued and pitocin augmentation begun. Amphotericin B was given for coverage of probable Candida albicans. The fetal heart rate pattern became non-reassuring with repetitive late decelerations, and an emergent cesarean was performed.
Clinical Perinatal/Neonatal Case Presentation
A 1390-gm female infant was delivered with Apgar scores of 6 and 8 at 1 and 5 minutes, respectively. Umbilical cord blood gases were compatible with respiratory acidemia. Physical examination of the neonate was remarkable for an erythematous rash with raised lesions over the face, chest, and abdomen. Early onset respiratory distress required endotracheal intubation and ventilation. After cultures were obtained, ampicillin, gentamicin, and amphotericin were administered. The initial white blood cell count was consistent with overwhelming sepsis at 1400/l. At 13 hours of age, intense cyanosis, hypotension, and bradycardia developed. Volume expansion, inotropic therapy, and cardiopulmonary resuscitation failed to revive the infant. Shortly before demise, pulmonary hemorrhage was diagnosed as the probable etiology for acute decompensation. Subsequently, blood and urine cultures returned no growth.
The maternal postoperative course was complicated by endometritis treated with intravenous, followed by oral, fluconazole for a total of 14 days. As in the first trimester, human immunodeficiency virus status was negative. Final amniotic fluid culture results were positive for moderate growth of C. albicans.
Autopsy findings were consistent with severe in utero systemic candidiasis. The placenta revealed acute inflammation of the membranes with numerous yeast spores and hyphal forms typical of fungal chorioamnionitis. Small, 0.1-cm yellow-white plaques covering the umbilical cord corresponded microscopically to Candida abscesses within Wharton's jelly (Figure 1 ). The erythematous rash revealed multiple intraepidermal microabscesses containing yeast spores. There was fulminant fungal pneumonia with acute inflammation, edema, numerous fungal hyphae and spores, and candidal invasion of the interstitium. Postmortem cultures of the blood, spleen, and lung were positive for C. albicans. The remainder of the examination was unremarkable and appropriate for gestational age.
Comment
With the increased use of diagnostic amniocentesis in preterm labor, the antepartum diagnosis of candidal chorioamnionitis is made more frequently. We believe ours is the first report of such after serial therapeutic amniocenteses.
Despite the high frequency of maternal vaginal candidal colonization (ϳ34%), 3 the rarity of monilial chorioamnionitis (6.5% of women in preterm labor with intact membranes and positive amniotic fluid cultures) 1 implies that factors beyond the presence of the fungus favor the initiation of placental and/or fetal infection. Four possible explanations have been proposed for Candida reaching the upper genital tract and causing chorioamnionitis: (1) direct invasion from the vagina after premature rupture of membranes, (2) sealed ruptures of the amnion, (3) migration across an intact amnion, and (4) a foreign body in the genital tract, such as an intrauterine contraceptive device or cerclage. 4 Cases of neonatal and placental candidiasis have been noted after premature rupture of the membranes with and without clinical "sealing." 1, 5 C. albicans has the ability to cross the amniotic membranes and cause degeneration of membrane epithelium in vitro. 6 Case series and individual reports have highlighted the possible etiologic role of the retained intrauterine contraceptive device and cervical cerclage. 3 In a prior case report of congenital mucocutaneous candidiasis after amniocentesis performed to assess fetal lung maturity, 7 it was conjectured that Candida could be introduced into the amniotic sac by the use of contaminated instruments, colonization of maternal skin, or puncture of fetal membranes allowing entry of ascending vaginal organisms. In the present case, infection related to repetitive amniocenteses may be an addition to the above list.
Once amniotic fluid invasion by Candida has occurred, chorioamnionitis, funisitis, and fetal infection may follow. 8 As in the current case, invasion of the interstitium of the lungs or lumen of the bowel may occur in severe infections, with dissemination of disease. Neonatal outcome remains dependent on gestational age and birth weight. 4 Although overall mortality is 33%, commonly due to pneumonitis, it is significantly increased among infants weighing Ͻ2000 gm 1 (as in this case). Early aggressive treatment with amphotericin B has been associated with improved survival.
Several unanswered questions remain regarding this case. Amniotic fluid was not evaluated for evidence of infection until the last reduction amniocentesis; therefore, we can only speculate regarding the timing of infection. However, as Candida is usually slow-growing, the infection likely had been present for some time to produce the severe sepsis seen at delivery. The patient's preterm cervical change, although initially minimal, may have facilitated an ascending infection. Also, no etiology for polyhydramnios was determined. Polyhydramnios has been associated with an increased risk of chorioamnionitis at term, 9 but no data exist on preterm gestations. Glucocorticoids have not been linked to Candida chorioamnionitis; it is doubtful that the course administered at 25 weeks' gestation was associated with this dismal outcome.
It is our recommendation that patients undergoing serial amniocenteses have amniotic fluid sent for Gram stain and culture, especially in the setting of severe polyhydramnios of unknown etiology. Antenatal detection of candidal chorioamnionitis may alter perinatal 
